Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Albumin Market Forecast: What Market Value Is Expected By 2030?

The market for albumin has experienced robust expansion recently, projecting a rise from $7.16 billion in 2025 to $7.81 billion in 2026, demonstrating a compound annual growth rate of 9.1%. This historic growth trend has been fueled by factors such as restricted supplies of plasma-derived albumin, an increasing incidence of liver conditions and burn injuries, greater incorporation into diagnostic testing kits, intensified biopharmaceutical research and development, and early integration into laboratory and research settings.

The albumin market is poised for substantial expansion in the ensuing years, with projections indicating a rise to $10.62 billion by 2030, driven by a compound annual growth rate of 8.0%. Factors fueling this anticipated growth include innovations in recombinant albumin technology, an increasing demand for personalized medical treatments, the broadened application of albumin within drug delivery mechanisms, an upswing in biopharmaceutical production, and escalating investments in therapeutic and cosmetic uses. Key developments anticipated within this timeframe encompass a heightened demand for human serum albumin in therapeutic applications, a greater utilization of albumin in vaccine and drug formulations, the expanding use of recombinant albumin across the biopharmaceutical sector, increased integration of albumin into cell culture media and diagnostic kits, and a concentrated emphasis on albumin-centric research initiatives and personalized healthcare approaches.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16333&type=smp

#Albumin Market Growth Factors: Which Forces Are Supporting Market Expansion?

An increasing prevalence of diabetes is anticipated to be a primary catalyst for the expansion of the albumin market. This chronic metabolic condition, marked by persistently high blood sugar, frequently leads to kidney issues like diabetic nephropathy. A significant contributor to the growing diabetes rates is the surge in obesity, a link firmly established by epidemiological studies indicating a pronounced association between elevated body mass index and a substantially increased risk of developing diabetes. Albumin plays a crucial role in managing these patients by aiding in the assessment of kidney health and informing therapeutic strategies for individuals with diabetes. As an illustration, the International Diabetes Federation (IDF), a non-profit entity headquartered in Belgium, reported in April 2025 that approximately 589 million adults and 9.5 million individuals with type 1 diabetes, which includes 1.9 million children and adolescents, were impacted by the disease globally in 2024, with projections suggesting this figure will climb to 853 million by the year 2050. Consequently, the escalating global incidence of diabetes is directly fueling the growth trajectory of the albumin market.

Albumin Market Categorization By Product Type And Application

The albumin market covered in this report is segmented –

1) By Type: Human Serum Albumin, Bovine Serum Albumin, Recombinant Albumin

2) By Application: Therapeutics, Drug Formulation And Vaccines, Component Of Media, Other Applications

3) By End-User: Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Research Institutes

Subsegments:

1) By Human Serum Albumin: Plasma-Derived Human Serum Albumin, Recombinant Human Serum Albumin, Human Serum Albumin For Therapeutic Use (In Liver Disease, Burns), Human Serum Albumin For Drug Delivery And Research Applications

2) By Bovine Serum Albumin: Bovine Serum Albumin For Laboratory Use (In Cell Culture), Bovine Serum Albumin For Diagnostic Kits, Bovine Serum Albumin As A Stabilizer In Vaccines And Biopharmaceuticals

3) By Recombinant Albumin: Recombinant Human Albumin For Therapeutic Applications, Recombinant Albumin For Biopharmaceutical Formulation, Recombinant Albumin For Cosmetic And Personal Care Applications, Recombinant Albumin For Research And Diagnostic Applications

Albumin Market Industry Trends: What Changes Are Reshaping Demand?

Leading players within the albumin sector are actively engaged in creating novel offerings, including a recombinant albumin free from animal and human origins, aimed at enhancing customer satisfaction through superior functionalities. This type of albumin is synthesized utilizing a non-mammalian host system, like yeast, and is entirely devoid of any animal or human-derived constituents. Illustratively, in March 2023, a collaboration was established between Albumedix, a UK entity specializing in recombinant human albumin (rHA) production, and Heartseed Inc., a Japanese biotechnology firm in its clinical development phase, to introduce Recombin. This essential excipient is slated for integration into the manufacturing process of Heartseed’s investigational cell therapy, HS-001, commencing with its initial human clinical trial. This partnership represents a pivotal advancement in the progression of HS-001, which holds considerable promise for transforming disease management approaches. The incorporation of recombinant technology throughout the production cycle guarantees the peak efficacy and durability of the cell therapy, thereby reinforcing its prospects for significant therapeutic outcomes.

Albumin Market Company Landscape And Strategic Competition

Major companies operating in the albumin market are Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Merck KGaA, Baxter International Inc., CSL Limited, Grifols SA, Mitsubishi Tanabe Pharma Corporation, Octapharma AG, Kedrion S.p.A., Biotest AG, Jiangxi Boya Bio-Pharmaceutical Co. Ltd., BPL (Bio Products Laboratory), Kamada Ltd., Proliant Biologicals, SeraCare Life Sciences Inc., HiMedia Laboratories, Albumedix Ltd., Medxbio Pte Ltd., Ventria Bioscience Inc., China Biologic Products Holdings Inc.

Access The Complete Albumin Market Report:

https://www.thebusinessresearchcompany.com/report/albumin-global-market-report

Albumin Market Largest Region By Revenue And Market Share

North Americawas the largest region in the albumin market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the albumin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model